ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Chemokine Receptors"

  • Abstract Number: 958 • 2017 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor-α Induces Production of Eotaxin-1/CCL11 from Fibroblast-like Synoviocyte in Rheumatoid Arthritis

    Kuninobu Wakabayashi, Takeo Isozaki, Airi Nishimi, Shinichiro Nishimi, Sho Ishii, Takahiro Tokunaga, Hidekazu Furuya and Tsuyoshi Kasama, Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan

    Background/Purpose: Chemokine C-C motif ligand 11 (CCL11) also known as eotaxin-1 is a member of the CC chemokine family, which acts as a major chemoattractant…
  • Abstract Number: 961 • 2017 ACR/ARHP Annual Meeting

    Adalimumab Reduces CXCR4 Expression during Inflammatory Arthritis and in Fibroblast-like Synoviocytes and Osteoclasts Under Chronic TNF Exposure

    Bohdan P. Harvey1, Li Li1, Mark Konrad1, Heather Knight1, Susan Westmoreland2, Melanie Ruzek1 and Zehra Kaymakcalan1, 1AbbVie Bioresearch Center, Worcester, MA, 2AbbVie Inc, AbbVie Bioresearch Center, Worcester, MA

    Background/Purpose: The CXCL12/CXCR4 chemokine axis has been implicated in the pathogenesis of RA. The expression of this chemokine and receptor has been shown to be…
  • Abstract Number: 1912 • 2017 ACR/ARHP Annual Meeting

    Broad Immunophenotyping Results: CCR10 Expressing CD8 T Cells Distinguish Psoriatic Arthritis from Psoriasis Limited to Skin Involvement

    Emmerik F.A. Leijten1,2, Tessa S. van Kempen1,2, Michel A.M. Olde Nordkamp1,2, Fleurieke H. Verhagen2,3, Sanne Hiddingh2,3, Jonas J.W. Kuiper2,3, Marianne L. Boes2,4 and Timothy R.D.J. Radstake1,2, 1Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Ophthalmology, University Medical Center Utrecht, Utrecht, Netherlands, 4Department of Pediatrics, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Studies that compare the immune cell phenotype or function from patients with psoriatic arthritis (PsA) to patients with psoriasis limited to cutaneous involvement (Pso)…
  • Abstract Number: 925 • 2016 ACR/ARHP Annual Meeting

    Complement C5a Receptor Is the Key Initiator of Neutrophil Adhesion and Inflammation in Immune Complex-Induced Arthritis

    Yoshishige Miyabe1, Chie Miyabe1, Thomas Murooka2, Edward Kim3, Nancy Kim3, Thorsten R. Mempel4 and Andrew D. Luster1, 1Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2University of Manitoba, Winnipeg, MB, Canada, 3Massachusetts General Hospital, Boston, MA, 4Massachusetts General Hospital, Charlestown, MA

    Background/Purpose: Inflammatory arthritis, including rheumatoid arthritis, is characterized by neutrophil (PMN) recruitment into the joint in a highly regulated process controlled by chemoattractants (CAs). Four…
  • Abstract Number: 1082 • 2016 ACR/ARHP Annual Meeting

    Type I/II Interferon Commits to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus

    Maiko Yoshikawa1, Shingo Nakayamada2, Satoshi Kubo3, Shigeru Iwata4, Kei Sakata5, Yusuke Miyazaki3, Kazuhisa Nakano2, Kazuyoshi Saito6 and Yoshiya Tanaka7, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyusyu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 4First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan, 6University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 7University of Occupational and Environmental Health, Kitakyushu, Japan

    Background/Purpose:  Systemic lupus erythematosus (SLE) is characterized by an expanded population of peripheral memory B cells. However, little is known about the qualitative abnormality of…
  • Abstract Number: 1920 • 2016 ACR/ARHP Annual Meeting

    Vitamin D Induces a Type 1 Regulatory T Cell (Tr1)-like Phenotype in Human C-C Chemokine Receptor Type 6 (Ccr6)+ th Cells and Promotes Their Migration to an Inflammatory Environment

    Wendy Dankers1, Jan Piet van Hamburg1, Nadine Davelaar1, Patrick Asmawidjaja1, Hoyan Wen1, Johannes van Leeuwen2, Edgar Colin3 and Erik Lubberts1, 1Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 2Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology, ZGT, Almelo, Netherlands

    Background/Purpose: The active vitamin D metabolite 1,25(OH)2D3 suppresses various experimental autoimmune diseases. In addition, serum vitamin D levels, vitamin D intake and polymorphisms in the…
  • Abstract Number: 2144 • 2016 ACR/ARHP Annual Meeting

    Functional Analysis of Macrophages in BehçEt’s Disease: C-C Chemokine Receptor Type 1 (CCR1) and IL-10 Are Implicated in Pathogenesis of the Disease

    Hiroto Nakano1, Yohei Kirino1, Momoko Ohno1, Kana Higashitani1, Mitsuhiro Takeno2, Ryusuke Yoshimi1 and Hideaki Nakajima3, 1Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 3Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan

    Background/Purpose: The recent GWAS and subsequent studies have identified susceptible genes such as CCR1 and IL10 genes, suggesting pathological roles of macrophages in Behçet's disease…
  • Abstract Number: 3040 • 2016 ACR/ARHP Annual Meeting

    Th17 Migration into the Synovial Fluid of Patients with Active Psoriatic Arthritis Is Enhanced By Regulatory T Cells

    Helen Baldwin1, Amara Ezeonyeji2, Mohammed Rohan Butt2 and Michael R. Ehrenstein3, 1Rheumatology, University College London, London, United Kingdom, 2Rheumatology, Medicine, University College London, London, United Kingdom, 3Medicine, University College London, London, United Kingdom

    Background/Purpose: Uncontrolled migration of Th17 cells into the skin and joints is a major driver in the pathogenesis of psoriatic arthritis (PsA). Modulation of T…
  • Abstract Number: 2009 • 2015 ACR/ARHP Annual Meeting

    CC-Chemokine Receptor 7 (CCR7) Deficiency Reduces Early Structural and Functional Features of Disease in a Murine Model of Osteoarthritis

    Nisha Sambamurthy1,2, Vu Nguyen1,2, Patrick Diviney3, Justin Gan4, Charles Bush-Joseph5, Susanna Chubinskaya6, Anne-Marie Malfait7, George Dodge2,3 and Carla R. Scanzello8,9, 1Medicine / Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Research, Philadelphia VA Medical Center, Philadelphia, PA, 3Orthopedics, University of Pennsylvania, Philadelphia, PA, 4Rheumatology, Rush University Medical Center, Chicago, IL, 5Orthopedics, Rush University Medical Center, Chicago, IL, 6Biochemistry, Rush University Medical Center, Chicago, IL, 7Rush University Medeical Center, Chicago, IL, 8Rheumatology, University of Pennsylvania, Philadelphia, PA, 9Rheumatology, University of Pennsylvania Perelman School of Medicine & Philadelphia VA Medical Center, Philadelphia, PA

    Background/Purpose: Synovial expression of CCR7 has been associated with inflammation and severity of symptoms in patients with meniscal tears and early osteoarthritis (OA). This receptor…
  • Abstract Number: 2013 • 2015 ACR/ARHP Annual Meeting

    TIARP Attenuates Autoantibody-Mediated Arthritis Via the Suppression of Neutrophil Infiltration into the Joint

    Asuka Inoue1, Isao Matsumoto1, Yuki Tanaka2, Naoto Umeda1, Hoshimi Kawaguchi1, Hiroshi Ebe1, Yoshihiro Matsumoto3 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Internal Medicine, University of Tsukuba, Tsukuba, Japan, 3Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan

    Background/Purpose: TIARP (TNFα-induced adipose-related protein) is dominantly expressed in macrophages (Mφ), neutrophils (PMN) and fibroblast-like synoviocytes (FLS). Recently, we found that TIARP functions as a…
  • Abstract Number: 2702 • 2015 ACR/ARHP Annual Meeting

    Immunophenotyping of Rheumatoid Arthritis Reveals the Linkage Between HLA-DRB1 Genotype, CXCR4 Expressions on Memory CD4+ T Cells, and Disease Activity

    Yasuo Nagafuchi1, Hirofumi Shoda1, Shuji Sumitomo1, Shinichiro Nakachi1, Rika Kato2, Yumi Tsuchida2, Haruka Tsuchiya2, Keiichi Sakurai2, Norio Hanata2, Shoko Tateishi2, Hiroko Kanda2, Keishi Fujio1 and Kazuhiko Yamamoto1, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Background/Purpose: The HLA-DRB1 is the strongest genetic risk factor for rheumatoid arthritis (RA). Although this fact suggests a pivotal role for adaptive immunity in RA,…
  • Abstract Number: 3201 • 2015 ACR/ARHP Annual Meeting

    IL-7 Drives Cytokine Secretion of IL-7Rabright CCR9-Expressing T-Follicular Helper-like Cells: Potential New Axis in Lymphoid Neogenesis in Salivary Glands of Primary Sjogren s Syndrome Patients

    S.L.M. Blokland1,2, M.R. Hillen1,2, A.A. Kruize1, A. Kislat3, S. Meller3, B. Homey3, G.M. Smithson4, J. Zalevsky5, T.R.D.J. Radstake1,2 and J.A.G. van Roon1,6, 1Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Department of Dermatology, University of Düsseldorf, Medical Faculty, Düsseldorf, Germany, 4Takeda Pharmaceuticals International, Chicago, IL, 5Takeda California, San Diego, CA, 6Laboratory for Translational immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: In primary Sjögren’s syndrome (pSS) B cell hyperactivity including autoantibody secretion and lymphoma development are hallmark immunopathological features. Specific lymphoid organization (including germinal centers)…
  • Abstract Number: 991 • 2015 ACR/ARHP Annual Meeting

    CaMK4 Facilitates Recruitment of IL-17 Producing Cells to Target Organs through the CCR6/CCL20 Axis in Th17-Driven Inflammatory Diseases

    Tomohiro Koga1,2, Kotaro Otomo3, Masayuki Mizui2, Nobuya Yoshida4, José C. Crispin2, Atsushi Kawakami5 and George C. Tsokos4, 1Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Medicine/Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 5Department of Immunology and Rheumatology, Nagasaki University, Nagasaki, Japan

    Background/Purpose: The recruitment of IL-17 producing T helper (Th17) cells to the inflammatory sites has been implicated in the development of organ damage in inflammatory…
  • Abstract Number: 1118 • 2015 ACR/ARHP Annual Meeting

    Role of the Chemokine Receptor CXCR3 in the Function of Regulatory B Cells in Patients with SLE

    Shun-ichiro Ota1,2, Hiroaki Niiro3, Naoko Ueki2,4, Yuri Hirosaki2, Hirofumi Tsuzuki2, Siamak Jabbarzadeh-Tabrizi2, Tsuyoshi Nakayama2, Koji Mishima2, Ayako Takaki2, Hiroki Mitoma2, Mitsuteru Akahoshi2, Yojiro Arinobu2, Hiroshi Tsukamoto2 and Koichi Akashi2, 1Department of Rheumatology, Internal medicine and connective tissue disorders, Shimonoseki City Hospital, Shimonoseki, Japan, 2Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, 3Clinical Education Center, Kyushu University Hospital, Fukuoka, Japan, 4Division of Nephrology and Rheumatology, Fukuoka University, Fukuoka, Japan

    Background/Purpose: The emerging application of B-cell directed therapies in autoimmune diseases has led to the discovery of a novel B cell population, referred to as…
  • Abstract Number: 1173 • 2015 ACR/ARHP Annual Meeting

    G Protein Coupled Receptor Kinase 3 Regulation of Inflammatory Arthritis

    Matthew J. Billard1, Roman Timoshchenko2, D. Stephen Serafin2 and Teresa K. Tarrant3, 1Medicine, University of North Carolina, Chapel Hill, NC, 2Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 3Rheumatology, University of North Carolina, Chapel Hill, NC

    Background/Purpose:   Chemokine receptors are G Protein Coupled Receptor (GPCR) family members that direct cell migration, differentiation, and survival in inflammatory conditions, but neutralization strategies…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology